Biological drugs, which have a complex structure, are far morecomplicated to produce than regular chemical drugs, which have a single molecular structure.
Don Berwick, former administrator of the US Centers for Medicare and Medicaid Services, says the challenge ahead is much morecomplicated than merely tweaking Medicare's funding structure.